IDH1 and IDH2 Gene Mutations in Omani Patients with Acute Myeloid Leukemia: Prognostic Significance and Clinic-pathologic Features
Objectives: We sought to define the prevalence of isocitrate dehydrogenase (IDH) mutations, evaluate the clinicopathologic impact of IDH mutations, assess the effect of IDH mutations on the response to the currently offered treatment for acute myeloid leukemia (AML) cases, and determine the impact o...
Автори: | Yusra Al Abri, Mohammed Al Huneini, Shoaib Al Zadjali, Mohammed Al Rawahi |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Oman Medical Specialty Board
2024-01-01
|
Серія: | Oman Medical Journal |
Предмети: | |
Онлайн доступ: | https://omjournal.org/articleDetails.aspx?coType=1&aId=3718 |
Схожі ресурси
Схожі ресурси
-
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
за авторством: Claudio Cerchione, та інші
Опубліковано: (2021-03-01) -
Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
за авторством: Ashkan Emadi, та інші
Опубліковано: (2016-03-01) -
Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
за авторством: Chotirat Sadudee, та інші
Опубліковано: (2012-03-01) -
IDH1-mutated relapsed or refractory AML: current challenges and future prospects
за авторством: Megías-Vericat JE, та інші
Опубліковано: (2019-06-01) -
Impact of IDH Mutations on DNA Methylation of Acute Myeloid Leukemia Related Genes: A Review Article
за авторством: Duha M. Bayram, та інші
Опубліковано: (2024-04-01)